(Q39406777)

English

A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease

scientific article published on 24 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease (English)

1 reference

Europe PubMed Central

11 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Tina Bianco-Miotto

3

1 reference

Europe PubMed Central

11 September 2017

6

0 references

4

0 references

Australian Prostate Cancer BioResource

10

object named as

Australian Prostate Cancer BioResource

1 reference

Europe PubMed Central

11 September 2017

9

object named as

Colleen C Nelson

1 reference

Europe PubMed Central

11 September 2017

12

object named as

Lisa M Butler

1 reference

Europe PubMed Central

11 September 2017

13

object named as

Wayne D Tilley

1 reference

Europe PubMed Central

11 September 2017

author name string

Vanessa C Thompson

1

1 reference

Europe PubMed Central

11 September 2017

Tanya K Day

2

1 reference

Europe PubMed Central

11 September 2017

Guangzhou Han

5

1 reference

Europe PubMed Central

11 September 2017

Grant Buchanan

7

1 reference

Europe PubMed Central

11 September 2017

Howard I Scher

8

1 reference

Europe PubMed Central

11 September 2017

Norman M Greenberg

11

1 reference

Europe PubMed Central

11 September 2017

language of work or name

0 references

publication date

24 January 2012

1 reference

Europe PubMed Central

11 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

11 September 2017

131

1 reference

Europe PubMed Central

11 September 2017

662-672

1 reference

Europe PubMed Central

11 September 2017

3

1 reference

Europe PubMed Central

11 September 2017

Integrative molecular concept modeling of prostate cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

A role for the androgen-receptor in clinically localized and advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Mutation of the androgen receptor causes oncogenic transformation of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Androgen Receptor (AR) Coregulators: An Overview

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Evolution of the androgen receptor: structure-function implications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Androgen regulation of gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Integrative genomic profiling of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Gene expression profiling predicts clinical outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Open source clustering software

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

GREB1 is a novel androgen-regulated gene required for prostate cancer growth.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

CCR2 expression correlates with prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26414

21 January 2018

Identifiers

10.1002/IJC.26414

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39406777&oldid=1826274077"